Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-01-06 00:52 | 2015-01-02 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; EVP | Retail-Drug Stores and Proprietary Stores | OPT+S | $95.28 | 347,343 | $33,096,439 | 23,419 | -93.7% |
| 2014-01-04 02:12 | 2014-01-02 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; EVP and President, Caremark | Retail-Drug Stores and Proprietary Stores | OPT+S | $70.54 | 790,888 | $55,785,522 | 46,400 | -94.5% |
| 2012-02-15 23:48 | 2012-02-13 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; EVP and President, Caremark | Retail-Drug Stores and Proprietary Stores | BUY | $42.99 | 46,400 | $1,994,736 | 69,798 | +198.3% |
| 2010-08-18 23:10 | 2010-08-17 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; President, Caremark Pharm Serv | Retail-Drug Stores and Proprietary Stores | BUY | $29.08 | 4,000 | $116,318 | 162,000 | +2.5% |
| 2010-08-11 23:00 | 2010-08-09 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; President, Caremark Pharm Serv | Retail-Drug Stores and Proprietary Stores | BUY | $29.86 | 11,000 | $328,460 | 158,000 | +7.5% |
| 2010-02-19 23:45 | 2010-02-17 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; President, Caremark Pharm Serv | Retail-Drug Stores and Proprietary Stores | BUY | $34.10 | 147,000 | $5,012,582 | 147,000 | +100.0% |
| 2010-01-07 00:27 | 2010-01-04 | CVS | CVS HEALTH Corp | Lofberg Per GH | Officer; President, Caremark Pharm Serv | Retail-Drug Stores and Proprietary Stores | BUY | $32.98 | 45,483 | $1,500,029 | 45,483 | +100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.